Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2022-01-07 00:00:00 ET · period of report 2022-01-06 · accession 0001209191-22-002429 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-07 | 2022-01-06 | MIRM | Peetz Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +40.0K | 68.0K | +143% | $0 |
| D | 2022-01-07 | 2022-01-06 | MIRM | Peetz Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +240.0K | 240.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-06 | A | A | 40,000 | $0.00 | 68,027 | D | — | — | (F1) Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan. |
| 2 | Derivative | Stock Option (right to buy) | 2022-01-06 | A | A | 240,000 | $0.00 | 240,000 | D | $15.87 · — to 2032-01-05 | 240,000 Common Stock | (F2) 1/4th of the shares vest one year after January 6, 2022 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. |